Research Solutions, Inc. has signed a $1 million enterprise agreement with a Fortune 500 biopharmaceutical company, marking the largest deal in the company's history. The agreement expands the customer's existing relationship with Research Solutions' Article Galaxy platform through an enterprise-wide deployment of Scite across its research groups.
The deployment will provide researchers and the company's internal tools with access to Scite's Smart Citations and scientific literature search capabilities. The agreement also includes full access to the Scite API and additional Scite datasets, enabling the biopharmaceutical company to integrate scientific literature search and evaluation capabilities into its existing workflows.
Large research and development organizations are increasingly developing systems to support evidence-based literature searches, mechanism-of-action research, patent landscaping, and pharmacovigilance. These applications require access to reliable scientific sources to support the accuracy and traceability of AI-generated information. General-purpose AI models may have limited coverage of scholarly literature and can produce inaccurate citations or fail to distinguish between supported and disputed research findings.
The agreement followed an enterprise evaluation lasting several months, which included product demonstrations, a technical trial, and reviews by the customer's procurement, legal, information security, technical architecture, and AI governance teams before receiving executive approval.
Under the agreement, the company will be able to use Scite's platform and API to search and evaluate peer-reviewed literature, identify supporting evidence for research findings, assess the reliability of claims, and retrieve licensed full-text content through its existing access entitlements. These capabilities are intended to support the integration of scientific evidence into the organization's internal AI tools and research workflows.
Click here to read the original press release.